297 related articles for article (PubMed ID: 8734079)
21. Microscopic polyangiitis: clinical aspects and treatment.
Lhote F; Cohen P; Généreau T; Gayraud M; Guillevin L
Ann Med Interne (Paris); 1996; 147(3):165-77. PubMed ID: 8796093
[TBL] [Abstract][Full Text] [Related]
22. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
Niles JL
Annu Rev Med; 1996; 47():303-13. PubMed ID: 8712783
[TBL] [Abstract][Full Text] [Related]
24. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa.
Bakkaloglu A; Ozen S; Baskin E; Besbas N; Gur-Guven A; Kasapçopur O; Tinaztepe K
Arch Dis Child; 2001 Nov; 85(5):427-30. PubMed ID: 11668111
[TBL] [Abstract][Full Text] [Related]
25. [Antineutrophil cytoplasmic antibody(ANCA)].
Yoshida M
Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
[TBL] [Abstract][Full Text] [Related]
26. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment.
Lhote F; Guillevin L
Rheum Dis Clin North Am; 1995 Nov; 21(4):911-47. PubMed ID: 8592743
[TBL] [Abstract][Full Text] [Related]
27. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement--a comparison of the clinical and laboratory features.
Kirkland GS; Savige J; Wilson D; Heale W; Sinclair RA; Hope RN
Clin Nephrol; 1997 Mar; 47(3):176-80. PubMed ID: 9105764
[TBL] [Abstract][Full Text] [Related]
28. [Classification of systemic vasculitides].
Guillevin L; Pagnoux C
Rev Prat; 2008 Mar; 58(5):480-6. PubMed ID: 18524103
[TBL] [Abstract][Full Text] [Related]
29. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome.
Lhote F; Cohen P; Guillevin L
Lupus; 1998; 7(4):238-58. PubMed ID: 9643314
[TBL] [Abstract][Full Text] [Related]
30. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment.
Guillevin L; Lhote F; Gherardi R
Neurol Clin; 1997 Nov; 15(4):865-86. PubMed ID: 9367969
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the Peripheral Nervous System in Polyarteritis Nodosa and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Imboden JB
Rheum Dis Clin North Am; 2017 Nov; 43(4):633-639. PubMed ID: 29061248
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
[TBL] [Abstract][Full Text] [Related]
33. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
[TBL] [Abstract][Full Text] [Related]
34. Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?
Baranger TA; Audrain MA; Testa A; Besnier D; Guillevin L; Esnault VL
Autoimmunity; 1995; 20(1):33-7. PubMed ID: 7578859
[TBL] [Abstract][Full Text] [Related]
35. Antineutrophil cytoplasmic antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Hauschild S; Csernok E; Schmitt WH; Gross WL
J Rheumatol; 1994 Jun; 21(6):1173-4. PubMed ID: 7932443
[No Abstract] [Full Text] [Related]
36. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Kallenberg CG
Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
[TBL] [Abstract][Full Text] [Related]
37. Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.
Boki KA; Dafni U; Karpouzas GA; Papasteriades C; Drosos AA; Moutsopoulos HM
Br J Rheumatol; 1997 Oct; 36(10):1059-66. PubMed ID: 9374922
[TBL] [Abstract][Full Text] [Related]
38. Anti-neutrophil cytoplasmic autoantibodies--a serologic marker for vasculitides.
Jennette JC; Falk RJ; Wilkman AS
Ann Acad Med Singap; 1995 Mar; 24(2):248-53. PubMed ID: 7653968
[TBL] [Abstract][Full Text] [Related]
39. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.
Watts R; Lane S; Hanslik T; Hauser T; Hellmich B; Koldingsnes W; Mahr A; Segelmark M; Cohen-Tervaert JW; Scott D
Ann Rheum Dis; 2007 Feb; 66(2):222-7. PubMed ID: 16901958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
